enXtra® - a 4th new study
A fourth study is completing the clinically proven enXtra®, the Alpinia galanga extract to improve alertness and focus up to 5 hours with and without caffeine
The new study ‘A Randomized Placebo Controlled Clinical Trial Demonstrating Safety & Efficacy of enXtra® in Healthy Adults’ has just been published. The cardiovascular safety was evaluated by assessing change in QT interval, blood pressure and heart rate. Further, other efficacy variables evaluated were change in perceived alertness and calmness, sleep disturbance and daytime sleepiness. None of the study group showed any significant change in the ECG or haemodynamic parameters as compared to baseline (p > 0.05). Post consumption, alertness and calmness scores were significantly increased in the enXtra® , and EnXtra® plus caffeine group (p < 0.001).